Literature DB >> 19136217

Schizotypy and nicotine, alcohol, and cannabis use in a non-psychiatric sample.

Michelle L Esterberg1, Sandra M Goulding, Erin B McClure-Tone, Michael T Compton.   

Abstract

Schizotypy is a multidimensional personality construct that is characterized by perceptual abnormalities, social withdrawal, mild suspiciousness, and odd thinking patterns. This study examined the relationship between four dimensions of self-reported schizotypy and substance use involving nicotine, alcohol, and cannabis, in undergraduate students. Results showed that higher levels of disorganized schizotypy, or odd thinking and behavior, were associated with greater indices of use of all three substances. Furthermore, higher cognitive-perceptual schizotypy was selectively associated with cannabis use. Results confirm findings of recent research that has discovered associations among schizotypy and substance use, highlighting links between behavioral traits and use of nicotine, alcohol, and cannabis. This study is one of the first to examine a wide range of schizotypy domains, and to show selective effects of the disorganized domain of schizotypy.

Entities:  

Mesh:

Year:  2008        PMID: 19136217     DOI: 10.1016/j.addbeh.2008.11.007

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  12 in total

1.  Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders.

Authors:  Deborah Hasin; Miriam C Fenton; Andrew Skodol; Robert Krueger; Katherine Keyes; Timothy Geier; Eliana Greenstein; Carlos Blanco; Bridget Grant
Journal:  Arch Gen Psychiatry       Date:  2011-11

2.  Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Glen P Davis; Michael T Compton; Shuai Wang; Frances R Levin; Carlos Blanco
Journal:  Schizophr Res       Date:  2013-11-05       Impact factor: 4.939

3.  Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.

Authors:  Anne Schmechtig; Jane Lees; Lois Grayson; Kevin J Craig; Rukiya Dadhiwala; Gerard R Dawson; J F William Deakin; Colin T Dourish; Ivan Koychev; Katrina McMullen; Ellen M Migo; Charlotte Perry; Lawrence Wilkinson; Robin Morris; Steve C R Williams; Ulrich Ettinger
Journal:  Psychopharmacology (Berl)       Date:  2013-02-22       Impact factor: 4.530

4.  Cannabis users differ from non-users on measures of personality and schizotypy.

Authors:  Daniel J Fridberg; Jennifer M Vollmer; Brian F O'Donnell; Patrick D Skosnik
Journal:  Psychiatry Res       Date:  2011-03-30       Impact factor: 3.222

5.  Deeper into schizotypy and motor performance: Investigating the nature of motor control in a non-psychiatric sample.

Authors:  Matthew W Roché; Mark L Fowler; Mark F Lenzenweger
Journal:  Psychiatry Res       Date:  2015-03-23       Impact factor: 3.222

6.  Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood.

Authors:  Deidre M Anglin; Cheryl M Corcoran; Alan S Brown; Henian Chen; Quenesha Lighty; Judith S Brook; Patricia R Cohen
Journal:  Schizophr Res       Date:  2012-02-09       Impact factor: 4.939

7.  DSM-IV schizotypal personality disorder: a taxometric analysis among individuals with and without substance use disorders in the general population.

Authors:  Bradley T Kerridge; Tulshi D Saha; Deborah S Hasin
Journal:  Ment Health Subst Use       Date:  2014

8.  Association of schizotypy with striatocortical functional connectivity and its asymmetry in healthy adults.

Authors:  Yi Wang; Ulrich Ettinger; Thomas Meindl; Raymond C K Chan
Journal:  Hum Brain Mapp       Date:  2017-10-11       Impact factor: 5.038

9.  Alcohol and Relatively Pure Cannabis Use, but Not Schizotypy, are Associated with Cognitive Attenuations.

Authors:  Daniela A Herzig; David J Nutt; Christine Mohr
Journal:  Front Psychiatry       Date:  2014-09-29       Impact factor: 4.157

10.  Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users.

Authors:  Koby Cohen; Shiri Rosenzweig; Paola Rosca; Albert Pinhasov; Abraham Weizman; Aviv Weinstein
Journal:  Front Psychiatry       Date:  2020-05-15       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.